December 2013.
All items were approved in accordance with the Notice calling the EGM.
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today, 17 September 2026, bought 2,500,000 shares in HBC in an off-market transaction at an...
Read MoreHofseth BioCare ASA ("HBC" or the "Company") today announces the appointment of Leif Arne Giske as new Chief Financial Officer (CFO) of the HBC Group, effective immediately. Mr. Giske has been with...
Read More